HRP20070527T3 - Benzothiazole derivatives for the treatment of diabetes - Google Patents
Benzothiazole derivatives for the treatment of diabetesInfo
- Publication number
- HRP20070527T3 HRP20070527T3 HR20070527T HRP20070527T HRP20070527T3 HR P20070527 T3 HRP20070527 T3 HR P20070527T3 HR 20070527 T HR20070527 T HR 20070527T HR P20070527 T HRP20070527 T HR P20070527T HR P20070527 T3 HRP20070527 T3 HR P20070527T3
- Authority
- HR
- Croatia
- Prior art keywords
- group
- diabetes
- treatment
- insulin resistance
- amino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03102740 | 2003-09-12 | ||
| PCT/EP2004/052090 WO2005025567A1 (en) | 2003-09-12 | 2004-09-08 | Benzothiazole derivatives for the treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20070527T3 true HRP20070527T3 (en) | 2007-12-31 |
Family
ID=34306921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20070527T HRP20070527T3 (en) | 2003-09-12 | 2004-09-08 | Benzothiazole derivatives for the treatment of diabetes |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20070088017A1 (https=) |
| EP (1) | EP1696909B1 (https=) |
| JP (1) | JP5021307B2 (https=) |
| AT (1) | ATE378047T1 (https=) |
| AU (1) | AU2004271740B2 (https=) |
| CA (1) | CA2534314C (https=) |
| CY (1) | CY1107820T1 (https=) |
| DE (1) | DE602004010178T2 (https=) |
| DK (1) | DK1696909T3 (https=) |
| ES (1) | ES2297494T3 (https=) |
| HR (1) | HRP20070527T3 (https=) |
| IL (1) | IL174250A (https=) |
| NO (1) | NO20061600L (https=) |
| PL (1) | PL1696909T3 (https=) |
| PT (1) | PT1696909E (https=) |
| SI (1) | SI1696909T1 (https=) |
| WO (1) | WO2005025567A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7838522B2 (en) * | 2004-11-17 | 2010-11-23 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
| BRPI0613042A2 (pt) | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
| KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 ｊｎｋ 억제제 |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP2382975A3 (en) | 2006-05-09 | 2012-02-29 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| ES2581765T3 (es) | 2006-08-24 | 2016-09-07 | University Of Tennessee Research Foundation | Acilanilidas sustituidas y métodos de uso de las mismas |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| EP2137173A2 (en) * | 2007-04-17 | 2009-12-30 | Laboratoires Serono SA | Process for the preparation of piperazine benzothiazoles |
| UA100527C2 (en) * | 2007-10-10 | 2013-01-10 | Астразенека Аб | Benzothiazoles as ghrelin receptor modulators |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
| US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| LT2872482T (lt) | 2012-07-13 | 2020-12-28 | Oncternal Therapeutics, Inc. | Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi |
| US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
| US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| WO2014114186A1 (zh) * | 2013-01-24 | 2014-07-31 | 山东亨利医药科技有限责任公司 | Jnk抑制剂 |
| WO2017025980A2 (en) * | 2015-08-12 | 2017-02-16 | Shoolineuniversity Of Biotechnology And Management Sciences | Novel benzothiazole derivatives with enhanced biological activity |
| CN115887434B (zh) * | 2022-11-23 | 2024-12-24 | 四川大学 | 具有抗氧化作用的药物用于制备治疗多囊卵巢综合征药物的用途 |
| US11905260B1 (en) | 2023-10-13 | 2024-02-20 | King Faisal University | N′-(1-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound |
| US11970467B1 (en) | 2023-10-13 | 2024-04-30 | King Faisal University | N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1176269A (en) * | 1981-03-02 | 1984-10-16 | Kazimir Sestanj | N-naphthoylglycine derivatives |
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6559188B1 (en) * | 1999-09-17 | 2003-05-06 | Novartis Ag | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes |
| EP1110957A1 (en) * | 1999-12-24 | 2001-06-27 | Applied Research Systems ARS Holding N.V. | Benzazole derivatives and their use as JNK modulators |
| WO2003047570A1 (en) * | 2001-12-07 | 2003-06-12 | Applied Research Systems Ars Holding N.V. | Benzazole derivatives for the treatment of scleroderma |
| JP4523289B2 (ja) * | 2002-04-25 | 2010-08-11 | メルク セローノ ソシエテ アノニム | 脳虚血障害又はｃｎｓ障害の処置のための薬剤としてのピペラジンベンゾチアゾール |
-
2004
- 2004-09-08 DE DE602004010178T patent/DE602004010178T2/de not_active Expired - Lifetime
- 2004-09-08 PT PT04787110T patent/PT1696909E/pt unknown
- 2004-09-08 WO PCT/EP2004/052090 patent/WO2005025567A1/en not_active Ceased
- 2004-09-08 JP JP2006525827A patent/JP5021307B2/ja not_active Expired - Fee Related
- 2004-09-08 DK DK04787110T patent/DK1696909T3/da active
- 2004-09-08 HR HR20070527T patent/HRP20070527T3/xx unknown
- 2004-09-08 AU AU2004271740A patent/AU2004271740B2/en not_active Ceased
- 2004-09-08 US US10/571,291 patent/US20070088017A1/en not_active Abandoned
- 2004-09-08 ES ES04787110T patent/ES2297494T3/es not_active Expired - Lifetime
- 2004-09-08 EP EP04787110A patent/EP1696909B1/en not_active Expired - Lifetime
- 2004-09-08 SI SI200430550T patent/SI1696909T1/sl unknown
- 2004-09-08 AT AT04787110T patent/ATE378047T1/de active
- 2004-09-08 CA CA2534314A patent/CA2534314C/en not_active Expired - Fee Related
- 2004-09-08 PL PL04787110T patent/PL1696909T3/pl unknown
-
2006
- 2006-03-12 IL IL174250A patent/IL174250A/en not_active IP Right Cessation
- 2006-04-07 NO NO20061600A patent/NO20061600L/no not_active Application Discontinuation
-
2007
- 2007-12-04 CY CY20071101543T patent/CY1107820T1/el unknown
-
2013
- 2013-10-08 US US14/048,690 patent/US20140107116A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL174250A (en) | 2011-01-31 |
| JP2007505083A (ja) | 2007-03-08 |
| JP5021307B2 (ja) | 2012-09-05 |
| DE602004010178T2 (de) | 2008-09-11 |
| PT1696909E (pt) | 2007-12-21 |
| DK1696909T3 (da) | 2008-01-02 |
| EP1696909B1 (en) | 2007-11-14 |
| US20140107116A1 (en) | 2014-04-17 |
| HK1096594A1 (en) | 2007-06-08 |
| NO20061600L (no) | 2006-04-07 |
| IL174250A0 (en) | 2006-08-01 |
| DE602004010178D1 (de) | 2007-12-27 |
| AU2004271740A1 (en) | 2005-03-24 |
| CY1107820T1 (el) | 2013-06-19 |
| EP1696909A1 (en) | 2006-09-06 |
| AU2004271740B2 (en) | 2010-10-28 |
| PL1696909T3 (pl) | 2008-04-30 |
| WO2005025567A1 (en) | 2005-03-24 |
| US20070088017A1 (en) | 2007-04-19 |
| ATE378047T1 (de) | 2007-11-15 |
| CA2534314C (en) | 2012-11-13 |
| SI1696909T1 (sl) | 2008-02-29 |
| CA2534314A1 (en) | 2005-03-24 |
| ES2297494T3 (es) | 2008-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20070527T3 (en) | Benzothiazole derivatives for the treatment of diabetes | |
| CO5650227A2 (es) | Derivados del acido propionico utiles en desordenes lipidicos | |
| TW200617001A (en) | Novel glucitol derivative, its prodrug, their salt and diabetic therapeutic agent containing the same | |
| BR0313290A (pt) | Derivado de pirazol, composição medicinal contendo o mesmo, uso medicinal dele, e intermediário para a sua produção | |
| IL173203A0 (en) | Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament | |
| NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| BRPI0413595B8 (pt) | sal de malonato, composição farmacêutica, uso de um sal de malonato, e, método de fabricação de um composto | |
| NO20053748L (no) | Pyrrolopyridazinderivater. | |
| AR041299A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
| NO20055854L (no) | (2-hyroksy-2-(4-hydroksy-3-hydroksymetylfenyl)--etylamino)-propylfenylderivater som beta2 agonister | |
| RU2005129999A (ru) | Диарилциклоалкильные производные, способы их получения и их применение в качестве лекарственного средства | |
| DE60335404D1 (de) | Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges | |
| ATE539743T1 (de) | Verfahren zur prävention und behandlung von ppar- vermittelten zuständen mit macelignan | |
| NO20054408L (no) | 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose | |
| IL166103A0 (en) | Pyrrolidine derivatives and their use | |
| DE602004019778D1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
| NO20061599L (no) | Benzoksazol acetonitriler | |
| AR039713A1 (es) | Derivados de acido benzoico orto sustituidos para el tratamiento de resistencia a la insulina | |
| MA27649A1 (fr) | Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci. | |
| DE60227008D1 (de) | Neue thiophenacylhydrazinoderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel, pharmazeutische zusammensetzungen und neue anwendungen | |
| ATE431148T1 (de) | Verwendung von cyclischen bioisosteren von purin- system-derivaten zur behandlung von erkrankungen durch störungen der nitrergen und dopaminergen systeme | |
| DK1755583T3 (da) | Anvendelse af neboglamin til behandling af skizofreni | |
| DK1614684T3 (da) | Diaminderivat, produktionsproces og antioxidantlægemiddel | |
| TH1701007595A (th) | อนุพันธ์เอไทนิลในฐานะโมดูเลเตอร์ของเมทาโบโทรปิกกลูตาเมตรีเซปเตอร์ |